Beneficial drugs for liver diseases
- PMID: 17966118
- DOI: 10.1002/jat.1310
Beneficial drugs for liver diseases
Abstract
Liver diseases are a major problem of worldwide proportions. However, the number of drugs actually used successfully in humans is very small. In this review some of the most promising/studied drugs utilized for liver diseases were chosen and analysed critically from the basic to the clinical point of view. Antiviral agents are not discussed because excellent reviews have appeared on this topic. The compounds/preparations described herein are, alphabetically: colchicine, corticosteroids, curcumin, glycyrrhizin, interferons (for their antifibrotic properties), Liv 52, nitric oxide, resveratrol, silymarin, sulfoadenosylmethionine, and thalidomide. Colchicine and corticosteroids have been studied extensively in animals and humans; most clinical studies suggest that these compounds are not useful in the treatment of liver diseases. Glycyrrhizin is an herbal medicine with several components that has interesting hepatoprotective properties in patients with subacute liver failure but deserves more prospective controlled trials. Interferon has shown interesting antifibrotic properties in animals and humans; prospective studies on their antifibrotic/fibrolytic activity are required. Curcumin, resveratrol and thalidomide are very attractive newly discovered protective and curative compounds on experimental hepatic diseases. Their mechanism of action is associated with the ability to down-regulate NF-kappaB and to decrease pronecrotic and profibrotic cytokines. Unfortunately, clinical studies are lacking. Sulfoadenosylmethionine and silymarin are also promising drugs utilized mainly in cholestasis but the benefits can be expanded if more controlled trials are performed. The future is to carry out controlled prospective double-blind multicenter studies with the newly discovered drugs with proven beneficial effects on animals. Fundamental hepatobiology should also be encouraged.
Similar articles
-
Herbal medicines for liver diseases.Dig Dis Sci. 2005 Oct;50(10):1807-12. doi: 10.1007/s10620-005-2942-9. Dig Dis Sci. 2005. PMID: 16187178 Review.
-
Drug development for liver diseases: focus on picroliv, ellagic acid and curcumin.Fundam Clin Pharmacol. 2008 Dec;22(6):623-32. doi: 10.1111/j.1472-8206.2008.00618.x. Fundam Clin Pharmacol. 2008. PMID: 19049667 Review.
-
Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine.Indian J Med Res. 2006 Nov;124(5):491-504. Indian J Med Res. 2006. PMID: 17213517 Review.
-
Herbal medicine in the treatment of liver diseases.Dig Liver Dis. 2007 Apr;39(4):293-304. doi: 10.1016/j.dld.2006.11.004. Epub 2007 Feb 28. Dig Liver Dis. 2007. PMID: 17331820 Review.
-
Use of herbal supplements for chronic liver disease.Clin Gastroenterol Hepatol. 2004 Nov;2(11):947-56. doi: 10.1016/s1542-3565(04)00455-0. Clin Gastroenterol Hepatol. 2004. PMID: 15551246 Review.
Cited by
-
An in vivo and in silico evaluation of the hepatoprotective potential of Gynura procumbens: A promising agent for combating hepatotoxicity.PLoS One. 2023 Sep 15;18(9):e0291125. doi: 10.1371/journal.pone.0291125. eCollection 2023. PLoS One. 2023. PMID: 37713406 Free PMC article.
-
In vitro and in vivo antioxidant activities of inulin.PLoS One. 2018 Feb 2;13(2):e0192273. doi: 10.1371/journal.pone.0192273. eCollection 2018. PLoS One. 2018. PMID: 29394273 Free PMC article.
-
An antioxidant resveratrol significantly enhanced replication of hepatitis C virus.World J Gastroenterol. 2010 Jan 14;16(2):184-92. doi: 10.3748/wjg.v16.i2.184. World J Gastroenterol. 2010. PMID: 20066737 Free PMC article.
-
Antioxidants in liver health.World J Gastrointest Pharmacol Ther. 2015 Aug 6;6(3):59-72. doi: 10.4292/wjgpt.v6.i3.59. World J Gastrointest Pharmacol Ther. 2015. PMID: 26261734 Free PMC article. Review.
-
The Protective Effect of Resveratrol on Concanavalin-A-Induced Acute Hepatic Injury in Mice.Gastroenterol Res Pract. 2015;2015:506390. doi: 10.1155/2015/506390. Epub 2015 May 24. Gastroenterol Res Pract. 2015. PMID: 26089871 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical